Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

40 Years of Preventing Fungal Infections in Hematological Malignancies - Lessons Learned from Clinical Trials with 20,753 Patients

Meinolf Karthaus, Michael G. Kiehl, Ilana Reinhold, Oliver A. Cornely, Jannik Stemler

Blood (2024) 144 (Supplement 1): 5187.

https://doi.org/10.1182/blood-2024-200029

Published: 2024

Journal Articles

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, Jaap van Doesum, Yavuz M. Bilgin, Alberto López-García, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerová, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valković, Iker Falces-Romero, Sonia Martín-Pérez, Moraima Jiménez, Julio Dávila-Valls, Martin Schönlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, László Imre Pinczés, Caterina Buquicchio, Klára Piukovics, Irati Ormazabal-Vélez, Nicola Fracchiolla, Michail Samarkos, Gustavo-Adolfo Méndez, José-Ángel Hernández-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta di Blasi, Joyce Marques de Almedia, Michelina Dargenio, Monika M. Biernat, Mariarita Sciumè, Cristina de Ramón, Nick de Jonge, Josip Batinić, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemí Fernández, Giovanni Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirkan, Lucia Prezioso, Zdeněk Ráčil, Marcio Nucci, Miloš Mladenović, Raphaël Liévin, Michaela Hanáková, Stefanie Gräfe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adžić-Vukičević, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver A. Cornely

Blood (2022) 140 (26): 2773–2787.

https://doi.org/10.1182/blood.2022017257

Published: 2022

Includes: Supplemental data

Journal Articles

SARS-CoV-2 vaccination in CLL: how often is enough?

Sibylle C. Mellinghoff, Oliver A. Cornely

Blood (2022) 140 (25): 2655–2657.

https://doi.org/10.1182/blood.2022018586

Published: 2022

Journal Articles

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Blood (2022) 139 (10): 1588–1592.

https://doi.org/10.1182/blood.2021014124

Published: 2022

Includes: Supplemental data

Journal Articles

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

Maria J.G.T. Vehreschild, MD, J. Janne Vehreschild, MD, Francisco M Marty, MD, John R Perfect, MD, Luis Ostrosky-Zeichner, MD, Galia Rahav, MD, Bernhardt Zeiher, MD, Misun Lee, PhD, Rochelle Maher, MD, Clint Lovell, MS, Marc Engelhardt, MD, Oliver A Cornely, MD

Blood (2014) 124 (21): 1151.

https://doi.org/10.1182/blood.V124.21.1151.1151

Published: 2014

Journal Articles

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Werner J Heinz, MD, Oliver A Cornely, MD, Billy Franks, PhD, Fei Shi, PhD, Nkechi Azie, MD, Johan Maertens, MD

Blood (2014) 124 (21): 1133.

https://doi.org/10.1182/blood.V124.21.1133.1133

Published: 2014

Journal Articles

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Blood (2013) 122 (21): 4552.

https://doi.org/10.1182/blood.V122.21.4552.4552

Published: 2013

Journal Articles

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Blood (2009) 114 (22): 4736.

https://doi.org/10.1182/blood.V114.22.4736.4736

Published: 2009

Journal Articles

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow Transplantation Group.

Catherine Cordonnier, MD, Hermann Einsele, MD, Montserrat Rovira, MD, Johan Maertens, Eduardo Olavarria, MD, Catherine Faucher, MD, Oliver A Cornely, MD, Rafael De La Camara, MD, Claus-Peter Heussel, MD, Marc Pineau, MD, Per T. Ljungman, MD, PhD

Blood (2008) 112 (11): 1159.

https://doi.org/10.1182/blood.V112.11.1159.1159

Published: 2008

Journal Articles

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

Oliver A. Cornely, MD, Johan Maertens, MD, Mark Bresnik, MD, Raoul Herbrecht, MD

Blood (2005) 106 (11): 3222.

https://doi.org/10.1182/blood.V106.11.3222.3222

Published: 2005

Journal Articles

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

Stefan Schwartz, Markus Ruhnke, Patricia Ribaud, Lawrence Corey, Timothy Driscoll, Oliver A. Cornely, Ulrich Schuler, Irja Lutsar, Peter Troke, Eckhard Thiel

Blood (2005) 106 (8): 2641–2645.

https://doi.org/10.1182/blood-2005-02-0733

Published: 2005

Journal Articles

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

Oliver A. Cornely, Andrew J. Ullmann, Meinolf Karthaus

Blood (2003) 101 (9): 3365–3372.

https://doi.org/10.1182/blood-2002-05-1356

Published: 2003

NARROW

40 Years of Preventing Fungal Infections in Hematological Malignancies - Lessons Learned from Clinical Trials with 20,753 Patients

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

SARS-CoV-2 vaccination in CLL: how often is enough?

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Investigation Of Fresh Tissue and Effusion Samples From Immunocompromised Hematologic Patients Suspected For Invasive Fungal Infection With An Aspergillus- specific PCR Is a Promising Tool For Identifying Invasive Aspergillosis

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow Transplantation Group.

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only